Key result
MIZAR 2.0 hemorheometer shows three precision categories for canine RBCs, with repeats impacting high-CV measurands.
Why the study?
Although hemorheology is promising in human medicine, its clinical utility in dogs remains unexplored, and assay validation is paramount for establishing reference intervals and interpreting data.
The MIZAR 2.0 hemorheometer demonstrates variable precision across different RBC measurands in canine blood, highlighting the need for assay validation before clinical use in dogs.
Hemorheologic measurements in dogs show variable precision by parameter and protocol; leaves open clinical utility pending validation.
Hemorheology, the study of blood flow properties, utilizes the deformability, elasticity, and aggregability of RBCs to assess health and disease. Although promising in human medicine for diagnosing and monitoring various conditions, its clinical utility in dogs remains unexplored. Given that assay validation is paramount for establishing RIs and interpreting hemorheologic data, we characterized the precision of 13 hemorheologic RBC measurands in dogs using a novel hemorheometer (MIZAR; Alcor Scientific). We investigated the influence of precision type (within- and between-run), temperature (room temperature and 4°C), number of repeats ( n 8–22), and wavelength of reading (620 and 800 nm) on measurement CVs. We found 3 distinct measurand categories: consistently low CVs, exemplified by optical transmission flow (OTF); consistently high CVs, exemplified by distribution index (DI); and condition-dependent CVs, exemplified by aggregation index (AI). For measurands with consistently high CVs, n had a greater impact on imprecision than any other factor. All other measurands had expected patterns of imprecision, with within-run measurements having the lowest CVs. Interestingly, measurand values did not significantly impact CVs in healthy dogs. For most measurands, CVs varied among samples handled similarly, which could be related to inter-individual variation; this observation may not necessarily affect the clinical accuracy of the hemorheometer in assessing clinically relevant changes in hemorheologic measurands during disease states.
No takes yet. Share an insight, caveat, or question.
Conrado et al. (2026) studied Healthy dogs. MIZAR 2.0 hemorheometer was evaluated on Measurement CVs of 13 hemorheologic RBC measurands. The MIZAR 2.0 hemorheometer demonstrated three distinct categories of precision for 13 hemorheologic RBC measurands in canine blood, with the number of repeats most impacting high-CV measurands.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: